ROLE OF GRB2-ASSOCIATED BINDER 1 (GAB1) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)-INDUCED SIGNALING IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

Por Hoeben, A., Martin, D., Clement, P. M., Cools, J., Gutkind, J. S.
Publicado em 2012

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing

Por Vanden Bempt, M, Demeyer, S, Mentens, N, Geerdens, E, De Bock, C E, Wlodarska, I, Cools, J
Publicado no Leukemia (2016)

Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system

Por Bornschein, S, Demeyer, S, Stirparo, R, Gielen, O, Vicente, C, Geerdens, E, Ghesquière, B, Aerts, S, Cools, J, de Bock, C E
Publicado no Leukemia (2018)

Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Por Degryse, S, de Bock, C E, Demeyer, S, Govaerts, I, Bornschein, S, Verbeke, D, Jacobs, K, Binos, S, Skerrett-Byrne, D A, Murray, H C, Verrills, N M, Van Vlierberghe, P, Cools, J, Dun, M D
Publicado no Leukemia (2018)

Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia

Por Degryse, S., de Bock, C. E., Demeyer, S., Govaerts, I., Bornschein, S., Verbeke, D., Jacobs, K., Binos, S., Skerrett-Byrne, D. A., Murray, H. C., Verrills, N. M., Van Vlierberghe, P., Cools, J., Dun, M. D.
Publicado no Leukemia (2018)